Header cover image

Spanish (IBEX) Pharma Industry Analysis

UpdatedDec 13, 2024
DataAggregated Company Financials
Companies5
  • 7D-1.8%
  • 3M-10.1%
  • 1Y5.5%
  • YTD1.9%

Over the last 7 days, the Pharma industry has dropped 2.3%, driven by declines in Faes Farma and Almirall of 4.3% and 2.5%, respectively. In the past year, the industry has gained 6.7%. Looking forward, earnings are forecast to grow by 26% annually.

Industry Valuation and Performance

Has the Spanish Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 13 Dec 2024€6.3b€2.7b€226.1m19.6x27.8x2.4x
Sun, 10 Nov 2024€6.5b€2.6b€235.9m20x27.6x2.5x
Tue, 08 Oct 2024€7.0b€2.5b€219.5m23.8x32x2.8x
Thu, 05 Sep 2024€7.2b€2.5b€219.5m23.6x32.8x2.8x
Sat, 03 Aug 2024€7.4b€2.5b€219.5m23.8x33.6x2.9x
Mon, 01 Jul 2024€7.8b€2.5b€202.7m24.3x38.7x3.1x
Wed, 29 May 2024€8.0b€2.6b€193.1m24.6x41.6x3.1x
Fri, 26 Apr 2024€7.4b€2.6b€223.6m21.1x33.1x2.9x
Sun, 24 Mar 2024€7.0b€2.6b€223.6m20.6x31.3x2.7x
Tue, 20 Feb 2024€6.8b€2.6b€295.8m17.3x23.1x2.6x
Thu, 18 Jan 2024€6.3b€2.6b€296.4m16.4x21.1x2.4x
Sat, 16 Dec 2023€6.0b€2.6b€296.4m15.5x20.3x2.3x
Mon, 13 Nov 2023€5.5b€2.5b€287.3m13.4x19.3x2.2x
Wed, 11 Oct 2023€6.0b€2.5b€274.5m15.6x22x2.4x
Fri, 08 Sep 2023€6.0b€2.5b€274.5m14.8x21.7x2.4x
Sun, 06 Aug 2023€5.5b€2.5b€274.5m13.2x20x2.2x
Tue, 04 Jul 2023€4.8b€2.4b€284.3m11.4x16.9x2x
Thu, 01 Jun 2023€4.9b€2.4b€284.3m11.4x17.3x2x
Sat, 29 Apr 2023€5.0b€2.4b€301.6m17.8x16.7x2.1x
Mon, 27 Mar 2023€4.8b€2.4b€301.6m17.3x16x2x
Wed, 22 Feb 2023€5.4b€2.3b€270.7m31.2x19.9x2.3x
Fri, 20 Jan 2023€4.9b€2.3b€275.8m28.3x17.7x2.1x
Sun, 18 Dec 2022€4.9b€2.3b€275.8m28.4x17.8x2.1x
Tue, 15 Nov 2022€5.1b€2.3b€303.6m25.6x16.7x2.2x
Thu, 13 Oct 2022€5.4b€2.3b€306.3m22.3x17.7x2.3x
Sat, 10 Sep 2022€5.6b€2.3b€306.3m26.1x18.3x2.4x
Mon, 08 Aug 2022€5.9b€2.3b€306.3m28.3x19.3x2.6x
Wed, 06 Jul 2022€6.5b€2.3b€225.4m17.1x29x2.9x
Fri, 03 Jun 2022€6.7b€2.2b€220.3m18.5x30.3x3x
Sun, 01 May 2022€7.2b€2.2b€200.5m23.4x36.2x3.4x
Tue, 29 Mar 2022€7.3b€2.1b€200.5m24.4x36.5x3.4x
Thu, 24 Feb 2022€7.3b€2.1b€158.5m35.9x45.8x3.5x
Sat, 22 Jan 2022€6.7b€2.0b€177.1m31.2x38x3.3x
Mon, 20 Dec 2021€7.1b€2.0b€177.1m34.2x39.8x3.4x
Price to Earnings Ratio

39.8x


Total Market Cap: €7.1bTotal Earnings: €177.1mTotal Revenue: €2.0bTotal Market Cap vs Earnings and Revenue0%0%0%
Spanish Pharma Industry Price to Earnings3Y Average 26.2x202220232024
Current Industry PE
  • Investors are relatively neutral on the Spanish Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 26.2x.
  • The industry is trading close to its 3-year average PS ratio of 2.6x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 8.5% per year over the last three years.
  • Revenues for these companies have grown 9.1% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Spanish Healthcare industry?

ES Market-3.39%
Healthcare3.09%
Pharma-1.82%
Pharma-1.82%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
LAB Labiana Health€2.084.0%
+€563.3k
90.8%PS0.2x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.